The results confirmed that ARL2 expression level significantly decreased in GBM (grade IV) (CGGA, Fig. 1d, P < 0.0001; Rembrandt database, Fig. 1e, P < 0.0001). This evidence concerns the gene ARL2 and glioblastoma.